Pyrido[2,3-b]pyrazine,
322-46-3,
1,4,5-Triazanaphthalene,
5-Azaquinoxaline,
Pyrido(2,3-b)pyrazine,
pyrido[3,2-b]pyrazine,
Pyrido(3,2-b)pyrazine,
EINECS 206-294-9,
NSC 73508,
BRN 0111634,
MFCD00006717,
F6170-0040,
NSC73508,
ACMC-20ahgw,
pyrido(2,3)pyrazine,
1,5-Triazanaphthalene,
pyridino[2,3-b]pyrazine,
SCHEMBL88611,
4-26-00-00168 (Beilstein Handbook Reference),
AC1L27V2,
WLN: T66 BN EN JNJ,
PYRIDO(2,3,B)PYRAZINE,
SCHEMBL19888585,
CTK1C3401,
KS-00000LCP,
YEYHFKBVNARCNE-UHFFFAOYSA-,
DTXSID30185970,
YEYHFKBVNARCNE-UHFFFAOYSA-N,
ZINC160376,
ACT10861,
ANW-73566,
NSC-73508,
SBB056351,
AKOS006228377,
MCULE-2258670998,
VZ20622,
AJ-15587,
AK-47060,
DS-14197,
SY039591,
ZB007361,
DB-048186,
LS-134004,
ST2407552,
TC-162311,
FT-0606755,
MFCD00006717 (97%),
L-4507,
195709-EP2272972A1,
195709-EP2272973A1,
195709-EP2277872A1,
195712-EP2272972A1,
195712-EP2272973A1,
195712-EP2277872A1,
A821210,
AC-907/25014161,
I14-61631,
InChI=1/C7H5N3/c1-2-6-7(9-3-1)10-5-4-8-6/h1-5H,
C7-H5-N3,
CID67580,